C
Concord Biotech Ltd
NSE:CONCORDBIO
Concord Biotech Ltd
NSE:CONCORDBIO
Price:
1 557.8
INR
0.29%
Market Closed
Market Cap:
163B
INR
Cash Flow Statement
Cash Flow Statement
Concord Biotech Ltd
Concord Biotech Ltd
Currency: INR
Millions
Annual
| Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||
| Net Income |
2 136
|
3 127
|
2 375
|
3 220
|
4 126
|
|
| Depreciation & Amortization |
213
|
275
|
501
|
540
|
536
|
|
| Other Non-Cash Items |
(92)
|
(95)
|
28
|
(52)
|
(162)
|
|
| Cash Taxes Paid |
491
|
752
|
608
|
703
|
1 033
|
|
| Cash Interest Paid |
3
|
0
|
53
|
38
|
26
|
|
| Change in Working Capital |
(708)
|
(1 639)
|
(828)
|
(1 249)
|
(1 845)
|
|
| Cash from Operating Activities |
1 548
N/A
|
1 668
+8%
|
2 075
+24%
|
2 460
+19%
|
2 655
+8%
|
|
| Investing Cash Flow | ||||||
| Capital Expenditures |
(1 555)
|
(2 042)
|
(1 555)
|
(1 451)
|
(857)
|
|
| Other Items |
427
|
90
|
437
|
(129)
|
(689)
|
|
| Cash from Investing Activities |
(1 128)
N/A
|
(1 952)
-73%
|
(1 118)
+43%
|
(1 580)
-41%
|
(1 546)
+2%
|
|
| Financing Cash Flow | ||||||
| Net Issuance of Debt |
374
|
368
|
(274)
|
(268)
|
(265)
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
(715)
|
|
| Other |
(808)
|
(57)
|
(728)
|
(584)
|
(13)
|
|
| Cash from Financing Activities |
(434)
N/A
|
311
N/A
|
(1 002)
N/A
|
(852)
+15%
|
(992)
-16%
|
|
| Change in Cash | ||||||
| Net Change in Cash |
(14)
N/A
|
27
N/A
|
(45)
N/A
|
28
N/A
|
116
+311%
|
|
| Free Cash Flow | ||||||
| Free Cash Flow |
(6)
N/A
|
(374)
-5 830%
|
520
N/A
|
1 009
+94%
|
1 798
+78%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
